Gene Therapy using anti-inflammatory cytokines promising against MS

 BioViva scientist Ali Fallah and his team work on novel gene therapy using anti-inflammatory cytokines and show that these can be a promising approach against multiple sclerosis (MS). 

Source:  Cell Journal.